ECHDC2 Antibody / Enoyl-CoA hydratase domain containing 2 Antibody (FY13672)

ECHDC2 Antibody by IHC in Human Liver Cancer Tissue. Immunohistochemistry analysis of ECHDC2 in a paraffin-embedded section of human liver cancer tissue using ECHDC2 Antibody. Brown DAB immunoreactivity is present in many tumor cells, predominantly in cytoplasmic regions, with heterogeneous intensity. Hematoxylin counterstaining reveals blue-purple nuclei and surrounding stromal elements. Heat-mediated antigen retrieval was performed using EDTA buffer at pH 8.0, followed by blocking with 10% goat serum. The section was incubated with 2 ug/ml primary antibody overnight at 4oC, followed by a peroxidase-conjugated secondary antibody and DAB detection. The Enoyl-CoA hydratase domain containing 2 Antibody staining is documented in this tumor section.

ECHDC2 Antibody by IHC in Human Prostate Cancer Tissue. Immunohistochemistry analysis of ECHDC2 expression in a paraffin-embedded human prostate cancer section using ECHDC2 Antibody. The image shows conspicuous brown DAB staining in a band of epithelial tumor cells lining a glandular or luminal structure, while the adjacent stromal region shows comparatively little labeling. Nuclei are counterstained blue with hematoxylin. The distribution of immunoreactivity is described from the visible section without assigning a specific intracellular organelle. This image provides tissue-level staining data for the Enoyl-CoA hydratase domain containing 2 Antibody in human prostate cancer.

ECHDC2 Antibody by WB in Rat and Mouse Tissue Lysates. Western blot analysis of ECHDC2 using ECHDC2 Antibody in four rodent tissues. Lanes 1-4 contain rat liver, rat heart, mouse liver and mouse heart lysates, respectively. The blot shows a strong band near 26-28 kDa in all four lanes, with an especially broad signal in the liver samples. Molecular weight markers are displayed alongside the lanes. The band position is consistent with the supplier-reported ECHDC2 immunoreactivity. This experiment documents antibody recognition in the tested tissues; the visible differences in band intensity should not be interpreted as quantitative differences in expression without loading normalization. The Enoyl-CoA hydratase domain containing 2 Antibody was used for detection.